Drug Shortage Report for PMS-DORZOLAMIDE-TIMOLOL

Last updated on 2020-06-09 History
Report ID 6120
Drug Identification Number 02442426
Brand name PMS-DORZOLAMIDE-TIMOLOL
Common or Proper name DORZOLAMIDE TIMOLOL
Company Name PHARMASCIENCE INC
Market Status DORMANT
Active Ingredient(s) TIMOLOL DORZOLAMIDE
Strength(s) 5MG 20MG
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC
Packaging size 10ML
ATC code S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-05-01
Estimated end date Unknown
Actual end date 2020-06-05
Shortage status Resolved
Updated date 2020-06-09
Company comments Product to be discontinued
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2020-06-09 French Compare
v14 2020-06-09 English Compare
v13 2018-02-22 French Compare
v12 2018-02-22 English Compare
v11 2017-09-19 English Compare
v10 2017-09-19 French Compare
v9 2017-09-19 English Compare
v8 2017-07-24 French Compare
v7 2017-07-24 English Compare
v6 2017-06-16 French Compare
v5 2017-06-16 English Compare
v4 2017-05-02 French Compare
v3 2017-05-02 English Compare
v2 2017-04-07 French Compare
v1 2017-04-07 English Compare

Showing 1 to 15 of 15